Formulation development and evaluation o... - tlooto, The Most Powerful AcademicGPT

To comprehensively address the development and evaluation of vonoprazan-incorporated nanosuspension over a 40–50 page academic document, a detailed, well-structured approach is essential. Below is an in-depth framework with expanded content suggestions and integration of relevant insights from recent nanosuspension research, tailored to vonoprazan, a potassium-competitive acid blocker with known solubility challenges. --- 1. Introduction 1.1 Background of the Study Vonoprazan fumarate is an innovative potassium-competitive acid blocker used widely for the treatment of acid-related gastrointestinal disorders including gastroesophageal reflux disease (GERD) and Helicobacter pylori infection. Despite its therapeutic advantages, vonoprazan exhibits suboptimal aqueous solubility, which limits its bioavailability and therapeutic performance in conventional oral formulations. Enhancing its solubility and dissolution rate through nanosizing techniques can potentially overcome these drawbacks.